Maelor's Volplex expands into Brazil:
This article was originally published in Clinica
Executive Summary
Maelor's blood plasma substitute product, Volplex, has extended its international reach with the recent appointment of a Brazilian distributor, Zodiac Productos Farmaceuticos. According to Maelor, Brazil's pharmaceutical market is just emerging from a major restructuring. The Wrexham, UK company has found marketing partners for the product in countries including South Africa, Bangladesh, Australia, China, and, most recently, South Korea.